It is not known what combination of bevacizumab and chemotherapy agents is the best therapeutic regimen. Comparative study results among the efficacies of bevacizumab plus chemotherapy remain controversial in patients with HER2-negative metastatic breast cancer. | Efficacy of bevacizumab combined with chemotherapy in the treatment of HER2- negative metastatic breast cancer A network meta-analysis